Study Finds No Increased Cancer Risk With Spironolactone Study Finds No Increased Cancer Risk With Spironolactone

Over 5 years, treatment with spironolactone for dermatologic conditions was not associated with a greater risk for breast or gynecologic cancers, when compared with women not using spironolactone.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology Source Type: news